SINGAPORE, Jan. 13, 2014 /PRNewswire/ - Zecotek Photonics
Inc. (TSXV: ZMS) (OTCPINK: ZMSPF) (Frankfurt: W1I), a developer
of leading-edge photonics technologies for medical, industrial and
scientific markets, today announced that the Company will be
attending the 2014 Cantech Investment Conference on January 16, 2014 in Toronto, Ontario. Dr. A. Faouzi Zerrouk, Chairman, President, and CEO
of Zecotek will be presenting at the conference at 11:25am EST. The Company will also have a
booth in the investor's exhibit hall.
This is a one day investment conference which brings
institutional and retail investors together with Canada's leading technology companies at the
Metro Toronto Convention Centre. It is the ultimate showcase
for Canadian technology development and investor
opportunities. Canadian icon Commander Chris Hadfield will take the stage as key note
speaker to remind Canadians that "The Sky is Not the Limit". Other
speakers include Canadian tech legend Sir Terry Matthews, Wellington Financial CEO
Mark McQueen, and OMERS Ventures CEO
John Ruffolo. The day will complete
with Cantech Letter's 4th annual Cantech Letter Awards
Dinner, recognizing the top achievement in Canadian
technology, clean technology and life science sectors.
For conference information please visit:
www.cambridgehouse.com.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics
technology company developing high-performance scintillation
crystals, photo detectors, positron emission tomography scanning
technologies, 3D auto-stereoscopic displays, and lasers for
applications in medical, high-tech and industrial sectors.
Founded in 2004, Zecotek operates three divisions: Imaging Systems,
Laser Systems and 3D Display Systems with labs located in
Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on
building shareholder value by commercializing over 50 patented and
patent pending novel photonic technologies directly and through
strategic alliances and joint ventures with leading industry
partners such as the European Organization for Nuclear Research
(Switzerland), Beijing Opto-Electronics Technology Co. Ltd.
(China), NuCare Medical Systems
(South Korea), and National
NanoFab Center (South
Korea). For more information visit www.zecotek.com,
follow @zecotek on Twitter and "like" us in Facebook at
www.facebook.com/zecotek.
This press release may contain forward-looking statements
that are based on management's expectations, estimates, projections
and assumptions. These statements are not guarantees of future
performance and involve certain risks and uncertainties, which are
difficult to predict. Therefore, actual future results and trends
may differ materially from what may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of the content of this news release. If you would like to
receive news from Zecotek in the future please visit the corporate
website at www.zecotek.com.
SOURCE Zecotek Photonics Inc.